Addition of biological functionality to poly(epsilon-caprolactone) films

Area of Science:

• Biomaterials Science
• Polymer Chemistry
• Cell Biology

Background:

• Biodegradable polyesters like poly(epsilon-caprolactone) (PCL) are widely used in biomedical applications.
• A key limitation of PCL is its inherent lack of biological functionality, hindering advanced applications.
• Enhancing PCL's bioactivity is crucial for improving its performance in tissue engineering and regenerative medicine.

Purpose of the Study:

• To develop a functionalized poly(epsilon-caprolactone) (PCL) polymer with enhanced cell adhesion properties.
• To investigate the conjugation of biomolecules to the modified PCL surface.
• To assess the impact of surface functionalization on fibroblast cell adhesion and spreading.

Main Methods:

• Synthesis of a PCL-based polymer functionalized with 4-nitrophenyl chloroformate (NPC) groups.
• Casting the functionalized polymer into thin films.
• Characterization of NPC functional groups using ATR-FTIR spectroscopy.
• Assessing film reactivity towards poly(l-lysine) (PLL) and GRGDS peptide.
• Evaluating 3T3 fibroblast adhesion and spreading on modified and unmodified PCL films.

Main Results:

• ATR-FTIR confirmed the presence of NPC functional groups on the PCL film surface.
• Successful conjugation and visualization of a fluorescent molecule demonstrated the functionalization methodology.
• Films treated with poly(l-lysine) or GRGDS showed significantly improved 3T3 fibroblast adhesion and spreading compared to unmodified PCL films.
• The NPC-functionalized PCL films exhibit enhanced biological interactivity.

Conclusions:

• The novel NPC-containing polymer provides a versatile platform for enhancing cellular adhesion on biodegradable polyester surfaces.
• This functionalization strategy allows for the facile coupling of specific molecules, such as peptides and proteins, to polymer substrates.
• The developed material holds significant potential for applications requiring improved cell integration, including tissue engineering scaffolds and implantable devices.